TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Duocort Pharma AB
Closing information (x1000 NOK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
13,362
|
17,776
|
15,877 |
| Financial expenses |
6
|
674
|
0 |
| Earnings before taxes |
81,229
|
10,485
|
9,413 |
| EBITDA |
87,090
|
19,610
|
17,039 |
| Total assets |
174,510
|
100,204
|
87,478 |
| Current assets |
174,510
|
93,861
|
74,129 |
| Current liabilities |
17,382
|
698
|
6,522 |
| Equity capital |
157,128
|
99,506
|
80,956 |
| - share capital |
98
|
105
|
95 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
90.0%
|
99.3%
|
92.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
607.9%
|
59.0%
|
59.3% |
| Return on assets (ROA) |
46.6%
|
11.1%
|
10.8% |
| Current ratio |
1004.0%
|
13447.1%
|
1136.6% |
| Return on equity (ROE) |
51.7%
|
10.5%
|
11.6% |
| Change turnover |
-3,185
|
180
|
-552 |
| Change turnover % |
-19%
|
1%
|
-3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.